Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rockwell Medical Technologies (RMTI)
NASDAQ:RMTI
Holding RMTI?
Track your performance easily
RMTI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.16 - $4.57
Previous Close$3.75
Volume376.33K
Average Volume (3M)521.60K
Market Cap
$116.36M
Enterprise Value$118.88M
Total Cash (Recent Filing)$11.86M
Total Debt (Recent Filing)$14.38M
Price to Earnings (P/E)―
Beta3.06
Next Earnings
Nov 11, 2024EPS Estimate
$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.17
Shares Outstanding31,030,218
10 Day Avg. Volume298,237
30 Day Avg. Volume521,602
Standard Deviation0.24
R-Squared0.10
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)4.93
Price to Sales (P/S)1.23
Price to Cash Flow (P/CF)19.40
P/FCF Ratio19.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.26
Enterprise Value/Gross Profit13.66
Enterprise Value/Ebitda98.33
Forecast
1Y Price Target
$7.50Price Target Upside100.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Rockwell Med News
PremiumCompany Announcements
Rockwell Med Unveils Updated Corporate Strategy Presentation
Ownership Overview
2.83% Insiders
4.57% Mutual Funds
<0.01% Other Institutional Investors
88.54% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RMTI FAQ
What was Rockwell Medical Technologies’s price range in the past 12 months?
Rockwell Medical Technologies lowest stock price was $1.16 and its highest was $4.57 in the past 12 months.
What is Rockwell Medical Technologies’s market cap?
Currently, no data Available
When is Rockwell Medical Technologies’s upcoming earnings report date?
Rockwell Medical Technologies’s upcoming earnings report date is Nov 11, 2024 which is in 7 days.
How were Rockwell Medical Technologies’s earnings last quarter?
Rockwell Medical Technologies released its earnings results on Aug 08, 2024. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of -$0.035 by $0.045.
Is Rockwell Medical Technologies overvalued?
According to Wall Street analysts Rockwell Medical Technologies’s price is currently Undervalued.
Does Rockwell Medical Technologies pay dividends?
Rockwell Medical Technologies does not currently pay dividends.
What is Rockwell Medical Technologies’s EPS estimate?
Rockwell Medical Technologies’s EPS estimate is $0.01.
How many shares outstanding does Rockwell Medical Technologies have?
Rockwell Medical Technologies has 31,030,218 shares outstanding.
What happened to Rockwell Medical Technologies’s price movement after its last earnings report?
Rockwell Medical Technologies reported an EPS of $0.01 in its last earnings report, beating expectations of -$0.035. Following the earnings report the stock price went up 20.904%.
Which hedge fund is a major shareholder of Rockwell Medical Technologies?
Currently, no hedge funds are holding shares in RMTI
---
Rockwell Med Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.50 (100.00% Upside)
$7.50 (100.00% Upside)
Blogger Sentiment
Bullish
RMTI Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.7%
Last 30 Days ▲ 13.9%
Last 30 Days ▲ 13.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
134.37%
12-Months-Change
Fundamentals
Return on Equity
-29.25%
Trailing 12-Months
Asset Growth
39.41%
Trailing 12-Months
Company Description
Rockwell Medical Technologies
Rockwell Medical, Inc. engages in targeting end-stage renal disease and chronic kidney disease. Its dialysis products include hemodialysis concentrates, citrapure, dri-sate, safety data sheets,ancillary products, and renal pure. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI.
---
RMTI Earnings Call
Q2 2024
0:00 / 0:00
---
RMTI Stock 12 Month Forecast
Average Price Target
$7.50
▲(100.00% Upside)
Technical Analysis
Aclaris Therapeutics
―
Actinium Pharmaceuticals
―
Clearside Biomedical
―
ESSA Pharma
―
Best Analysts Covering RMTI
1 Year
1 Year Success Rate
8/13 ratings generated profit
1 Year Average Return
+31.55%
reiterated a buy rating 2 months ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +31.55% per trade.
---